ClinicalTrials.Veeva

Menu

Trial Using Integuseal as Microbial Sealant for Arterial Bypass Surgery on Lower Extremities (ITT)

R

Rijnstate Hospital

Status

Terminated

Conditions

Arterial Obstructive Diseases

Treatments

Procedure: Application of Integuseal sealant

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00940979
LTC 625-230609

Details and patient eligibility

About

The purpose of this study is to prove a reduction of postoperative wound infections after direct preoperative use of a microbial sealant in the form of Integuseal for vascular procedures on lower extremities.

Enrollment

450 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • planned supragenual of infragenual peripheral arterial bypass procedures with autologue or prosthetic graft

Exclusion criteria

  • secondary procedures and suprainguinal procedures

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

450 participants in 2 patient groups

No use of integuseal
No Intervention group
Use of Integuseal
Experimental group
Description:
Application of a layer of Integuseal (Cyanoacrylate) from a ready to use applicator preoperative before incision Polymerisation immobilise the bacteria that survived the conventional skin preparation This way there will be les contamination of the wound.
Treatment:
Procedure: Application of Integuseal sealant

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems